Atlas Trials

Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer

Clinical trial NCT03038217 · UNKNOWN

Trial details

NCT number
NCT03038217
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Start date
2017-02-01
Primary completion
2020-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.